Dearborn Partners LLC Has $351,000 Stake in CME Group Inc. (NASDAQ:CME)

Dearborn Partners LLC increased its holdings in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 5.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,512 shares of the financial services provider’s stock after buying an additional 77 shares during the period. Dearborn Partners LLC’s holdings in CME Group were worth $351,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of the business. Truvestments Capital LLC acquired a new position in CME Group in the third quarter valued at about $26,000. SJS Investment Consulting Inc. raised its position in shares of CME Group by 570.6% in the 4th quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 97 shares during the period. Dunhill Financial LLC boosted its stake in CME Group by 188.4% during the 3rd quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock worth $27,000 after acquiring an additional 81 shares during the last quarter. Financial Life Planners acquired a new position in CME Group during the fourth quarter valued at approximately $32,000. Finally, Fortitude Family Office LLC grew its holdings in CME Group by 120.3% during the fourth quarter. Fortitude Family Office LLC now owns 152 shares of the financial services provider’s stock valued at $35,000 after purchasing an additional 83 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on the stock. JPMorgan Chase & Co. lifted their price target on shares of CME Group from $209.00 to $212.00 and gave the stock an “underweight” rating in a research report on Thursday, February 13th. Morgan Stanley increased their price target on CME Group from $256.00 to $263.00 and gave the stock an “equal weight” rating in a report on Wednesday, February 19th. Keefe, Bruyette & Woods lifted their price objective on CME Group from $256.00 to $257.00 and gave the company a “market perform” rating in a report on Friday, February 14th. Barclays boosted their price objective on CME Group from $257.00 to $263.00 and gave the company an “equal weight” rating in a research report on Thursday, February 13th. Finally, Citigroup downgraded shares of CME Group from a “buy” rating to a “neutral” rating and dropped their target price for the stock from $255.00 to $250.00 in a report on Monday, January 6th. Four research analysts have rated the stock with a sell rating, eight have given a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $238.93.

Check Out Our Latest Analysis on CME

Insiders Place Their Bets

In other CME Group news, insider Julie Winkler sold 11,592 shares of the stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $249.17, for a total value of $2,888,378.64. Following the transaction, the insider now directly owns 21,885 shares of the company’s stock, valued at $5,453,085.45. This represents a 34.63 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Hilda Harris Piell sold 3,984 shares of the firm’s stock in a transaction that occurred on Thursday, February 27th. The stock was sold at an average price of $250.47, for a total transaction of $997,872.48. Following the sale, the insider now owns 27,046 shares of the company’s stock, valued at $6,774,211.62. This trade represents a 12.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 17,076 shares of company stock valued at $4,271,496 over the last 90 days. 0.30% of the stock is currently owned by insiders.

CME Group Trading Down 0.7 %

CME Group stock opened at $260.43 on Wednesday. The company has a market cap of $93.85 billion, a price-to-earnings ratio of 26.93, a P/E/G ratio of 6.76 and a beta of 0.53. The firm has a 50-day moving average of $241.25 and a 200-day moving average of $231.60. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02. CME Group Inc. has a one year low of $190.70 and a one year high of $263.65.

CME Group (NASDAQ:CMEGet Free Report) last posted its quarterly earnings results on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share for the quarter, beating analysts’ consensus estimates of $2.46 by $0.06. CME Group had a return on equity of 13.62% and a net margin of 57.52%. On average, equities analysts expect that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Friday, March 7th will be given a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.92%. The ex-dividend date of this dividend is Friday, March 7th. This is an increase from CME Group’s previous quarterly dividend of $1.15. CME Group’s dividend payout ratio (DPR) is 51.71%.

CME Group announced that its board has authorized a share buyback program on Thursday, December 5th that permits the company to buyback $3.00 billion in shares. This buyback authorization permits the financial services provider to reacquire up to 3.4% of its shares through open market purchases. Shares buyback programs are typically a sign that the company’s board believes its shares are undervalued.

CME Group Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

See Also

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.